Industry News

Penn Physicist, Physician Team Awarded $2 Million NIH Grant to Develop Portable COVID-19 Detector for Use in Public Spaces

01/21/2021

Excerpt from the Article: PHILADELPHIA — A team led by physicists at the University of Pennsylvania and physicians at the University’s Perelman School of Medicine has been awarded a two-year, $2 million grant by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences for the development of a handheld device that can…

Read More

Cyxone reports first Covid-19 patient screened in Phase 2 clinical trial of Rabeximod

01/20/2021

Excerpt from the Press Release: STOCKHOLM, Jan. 15, 2021 /PRNewswire/ — Cyxone (publ.) announced today that the first patient has been screened in the Phase 2 clinical trial of Rabeximod in Covid-19. The trial will evaluate the efficacy and safety of oral treatment with Rabeximod to prevent disease progression in hospitalized Covid-19 patients and shorten…

Read More

Non-Invasive Imaging Can Measure Cell Dysfunction in Patients with ALS

01/19/2021

Excerpt from the Article: A new non-invasive magnetic resonance spectroscopy technique could help providers measure how well treatments are working for patients with amyotrophic lateral sclerosis (ALS), new research has found. Specifically known as 31-phosphorus magnetic resonance spectroscopy can measure how well the mitochondria is working in patients who have this motor neuron disease (MND),…

Read More

Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in Patients with Mild-to-Moderate COVID-19

01/19/2021

Excerpt from the Press Release: LEXINGTON, Mass., Jan. 14, 2021 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), today announced positive interim results from the K031 non-IND controlled clinical study evaluating outpatients with mild to moderate COVID-19 disease. Patients in this non-IND clinical study were randomized within 48 hours of testing positive for COVID-19 to…

Read More

17 Black innovators who made medtech better

01/18/2021

Excerpt from the Article: From cardiology to endoscopy to blood transfusion, African Americans have played an important role as innovators in the history of medicine and medtech. To help mark African American History Month, here’s a look at some of their greatest achievements. Here are 17 African American innovators who have made discoveries and invented…

Read More

Chest Imaging Shows Little Long-Term Lung Scarring from COVID-19

01/18/2021

Excerpt from the Article: How well a patient’s lungs recover post-COVID-19 infection is not necessarily linked with the severity of his or her disease course, but imaging shows that most patients do not experience long-term fibrosis. To date, little research has focused on lung health post-recovery, and not much is known about whether the lingering…

Read More

Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives FDA Fast Track Designation

01/18/2021

Excerpt from the Press Release: Phase 2 clinical trial of Brilacidin for COVID-19 anticipated to commence this month Email Print Friendly ShareJanuary 14, 2021 07:30 ET | Source: Innovation Pharmaceuticals Inc. WAKEFIELD, Mass., Jan. 14, 2021 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to announce that the…

Read More

COVID-19 Lung Involvement Captured on CT Can Help Predict Mortality Risk

01/16/2021

Excerpt from the Article: Chest CT scans can provide a volumetric analysis of lung consolidation in COVID-19-positive patients, helping providers with care management and better enabling them to pinpoint which patients could die in the hospital from the virus. In a study published Jan. 6 in the European Journal of Radiology Open, investigators from Michigan…

Read More

Mayo validates COVID-19 plasma treatment as public seeks vaccine

01/15/2021

Excerpt from the Article: Donor plasma from patients who have recovered from COVID-19 can reduce deaths in others if given early and at high enough doses, Mayo Clinic researchers found. The discovery validates one of COVID-19’s only known treatments, which will be relied on until an increase in vaccinations snuffs out the global pandemic, said…

Read More

Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure

01/15/2021

Excerpt from the Press Release: SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc. (Nasdaq: ILMN) and Helix today announced a collaboration to augment national surveillance infrastructure in the US to track the emergence and prevalence of novel strains of SARS-CoV-2 with support from the CDC. The combination of Illumina’s sequencing technology and expertise and Helix’s national COVID-19 testing…

Read More